Efficacy and safety of ixazomib in patients with relapsed/refractory multiple myeloma in the real world: meta-analysis of single proportions

Li Yun, Li Bingsheng, Yuan Zhen, Liu Bin, Li Yixiu, Ao Jian'gen

PDF(2050 KB)
PDF(2050 KB)
Adverse Drug Reactions Journal ›› 2023, Vol. 25 ›› Issue (10) : 614-621. DOI: 10.3760/cma.j.cn114015-20221227-01184

Efficacy and safety of ixazomib in patients with relapsed/refractory multiple myeloma in the real world: meta-analysis of single proportions

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2023, 25(10): 614-621 https://doi.org/10.3760/cma.j.cn114015-20221227-01184

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(2050 KB)

Accesses

Citation

Detail
Sections
Recommended

/

〈 〉